De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Clinical trial NCT07303686 · RECRUITING

Trial details

NCT number: NCT07303686
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease (CD)Ulcerative Colitis (UC)

Start date: 2025-10-08
Primary completion: 2027-04-15
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.